Fredun Pharmaceuticals Limited (NSE:FREDUN)
India · Delayed Price · Currency is INR 1,390.00
+7.40 (0.54%)
Last updated: Sep 23, 2026, 3:29 PM IST
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 23.08 billion as of September 23, 2026. Its market cap has increased by 301.67% in one year.
Market Cap
23.08B
Enterprise Value
24.85B
Revenue
7.44B
Ranking
n/a
PE Ratio
59.19
Stock Price
1,390.00
ChartMarket Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.40M to 23.08B, an increase of 78,377.81%. That is a compound annual growth rate of 88.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 23.08B | 209.66% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 56.16B |
| RPG Life Sciences | 45.43B |
| Solara Active Pharma Sciences | 35.92B |
| Ind-Swift Laboratories | 35.27B |
| Sakar Healthcare | 26.44B |
| Indoco Remedies | 23.49B |
| Windlas Biotech | 22.75B |
| Beta Drugs | 21.34B |